[HTML][HTML] Evaluation of SARS-CoV-2 serology assays reveals a range of test performance

…, LA Farrington, RP Loudermilk, K Koshal… - Nature …, 2020 - nature.com
Appropriate use and interpretation of serological tests for assessments of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) exposure, infection and potential immunity …

[HTML][HTML] Test performance evaluation of SARS-CoV-2 serological assays

…, LA Farrington, R Loudermilk, K Koshal… - Nature …, 2020 - ncbi.nlm.nih.gov
Appropriate use and interpretation of serological tests for assessments of SARS-CoV-2
exposure, infection and potential immunity require accurate assay performance data. We …

A pathogenic and clonally expanded B cell transcriptome in active multiple sclerosis

…, MT Koelzer, EB Tran, K Koshal… - Proceedings of the …, 2020 - National Acad Sciences
Central nervous system B cells have several potential roles in multiple sclerosis (MS):
secretors of proinflammatory cytokines and chemokines, presenters of autoantigens to T cells, …

[HTML][HTML] A closed-loop falls monitoring and prevention app for multiple sclerosis clinical practice: human-centered design of the multiple sclerosis falls insighttrack

VJ Block, K Koshal, J Wijangco, N Miller… - JMIR Human …, 2024 - humanfactors.jmir.org
Background: Falls are common in people with multiple sclerosis (MS), causing injuries, fear
of falling, and loss of independence. Although targeted interventions (physical therapy) can …

[HTML][HTML] A Closed-Loop Digital Health Tool to Improve Depression Care in Multiple Sclerosis: Iterative Design and Cross-Sectional Pilot Randomized Controlled Trial …

K Henderson, J Reihm, K Koshal… - JMIR Formative …, 2024 - formative.jmir.org
Background People living with multiple sclerosis (MS) face a higher likelihood of being
diagnosed with a depressive disorder than the general population. Although many low-cost …

Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS CATCH study …

K Henderson, J Reihm, K Koshal, J Wijangco… - BMJ open, 2024 - bmjopen.bmj.com
Introduction Depression occurs in over 50% of individuals living with multiple sclerosis (MS)
and can be treated using many modalities. Yet, it remains: under-reported by patients, under-…

[HTML][HTML] Protocol: Pragmatic phase II clinical trial to improve depression care in a real-world diverse MS cohort from an academic MS centre in Northern California: MS …

K Henderson, J Reihm, K Koshal, J Wijangco, N Miller… - BMJ Open, 2024 - ncbi.nlm.nih.gov
Introduction Depression occurs in over 50% of individuals living with multiple sclerosis (MS)
and can be treated using many modalities. Yet, it remains: underreported by patients, under-…

[HTML][HTML] Cognitive Function Influences Cognitive-Motor Interference During Dual Task Walking in Multiple Sclerosis

…, K Henderson, A Nylander, K Koshal… - Multiple Sclerosis and …, 2024 - Elsevier
Background Both physical and cognitive impairments are common in people with multiple
sclerosis (PwMS). Performing a cognitive task while walking (ie, dual-task walking) can …

Spatio-Temporal Gait Parameters to Distinguish Multiple Sclerosis Disability during Dual-Task Walk

…, J DePaoli, J Wijangco, K Henderson, K Koshal… - Multiple Sclerosis and …, 2023 - Elsevier
Background Differences in gait between people with multiple sclerosis (PwMS) and controls
are well documented and effective in distinguishing between disability levels based on the …

Face Validity: Digital Facial Analysis Recapitulates Clinical Findings of Neurological Disease (P10-4.002)

A Nylander, K Henderson, K Koshal, N Sisodia… - Neurology, 2024 - AAN Enterprises
Objective: To distinguish characteristic facial phenotypes of neurologic disease using computer
vision-based facial movement analysis. Background: Neurological diseases can present …